Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben M Dunn

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Biochemistry|December 24, 2003
Secondary mutations M36I and A71V in the human immunodeficiency virus type 1 protease can provide an advantage for the emergence of the primary mutation D30NJosé C Clemente, Reena Hemrajani, Lisa E Blum, et al.
BMC Structural Biology|November 12, 2003
A model of tripeptidyl-peptidase I (CLN2), a ubiquitous and highly conserved member of the sedolisin family of serine-carboxyl peptidasesAlexander Wlodawer, Stewart R Durell, Mi Li, et al.
Journal of Virology|July 29, 2004
Initial cleavage of the human immunodeficiency virus type 1 GagPol precursor by its activated protease occurs by an intramolecular mechanismSteven C Pettit, Lorraine E Everitt, Sumana Choudhury, et al.
Journal of Virology|July 30, 2005
Ordered processing of the human immunodeficiency virus type 1 GagPol precursor is influenced by the context of the embedded viral proteaseSteven C Pettit, Jose C Clemente, Jennifer A Jeung, et al.
Antiviral Therapy|March 23, 2012
Kinetic characterization of newly discovered inhibitors of various constructs of human T-cell leukemia virus-1 (HTLV-1) protease and their effect on HTLV-1-infected cellsAhu Demir, Raphael M Oguariri, Andrew Magis, et al.
Journal of the American Chemical Society|October 1, 2009
Subtype polymorphisms among HIV-1 protease variants confer altered flap conformations and flexibilityJamie L Kear, Mandy E Blackburn, Angelo M Veloro, et al.
Bioorganic & Medicinal Chemistry|July 29, 2009
alpha-Substituted norstatines as the transition-state mimic in inhibitors of multiple digestive vacuole malaria aspartic proteasesKristina M Orrling, Melissa R Marzahn, Hugo Gutiérrez-de-Terán, et al.
The FEBS Journal|September 29, 2011
Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus proteaseMi Li, Alla Gustchina, Krisztina Matúz, et al.
Journal of Biochemistry|May 2, 2002
A CLN2-related and thermostable serine-carboxyl proteinase, kumamolysin: cloning, expression, and identification of catalytic serine residueHiroshi Oyama, Takatoshi Hamada, Shin Ogasawara, et al.
Biochemical and Biophysical Research Communications|January 22, 2004
Two inhibitor molecules bound in the active site of Pseudomonas sedolisin: a model for the bi-product complex following cleavage of a peptide substrateAlexander Wlodawer, Mi Li, Alla Gustchina, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Biochemistry|December 24, 2003
Secondary mutations M36I and A71V in the human immunodeficiency virus type 1 protease can provide an advantage for the emergence of the primary mutation D30NJosé C Clemente, Reena Hemrajani, Lisa E Blum, et al.
BMC Structural Biology|November 12, 2003
A model of tripeptidyl-peptidase I (CLN2), a ubiquitous and highly conserved member of the sedolisin family of serine-carboxyl peptidasesAlexander Wlodawer, Stewart R Durell, Mi Li, et al.
Journal of Virology|July 29, 2004
Initial cleavage of the human immunodeficiency virus type 1 GagPol precursor by its activated protease occurs by an intramolecular mechanismSteven C Pettit, Lorraine E Everitt, Sumana Choudhury, et al.
Journal of Virology|July 30, 2005
Ordered processing of the human immunodeficiency virus type 1 GagPol precursor is influenced by the context of the embedded viral proteaseSteven C Pettit, Jose C Clemente, Jennifer A Jeung, et al.
Antiviral Therapy|March 23, 2012
Kinetic characterization of newly discovered inhibitors of various constructs of human T-cell leukemia virus-1 (HTLV-1) protease and their effect on HTLV-1-infected cellsAhu Demir, Raphael M Oguariri, Andrew Magis, et al.
Journal of the American Chemical Society|October 1, 2009
Subtype polymorphisms among HIV-1 protease variants confer altered flap conformations and flexibilityJamie L Kear, Mandy E Blackburn, Angelo M Veloro, et al.
Bioorganic & Medicinal Chemistry|July 29, 2009
alpha-Substituted norstatines as the transition-state mimic in inhibitors of multiple digestive vacuole malaria aspartic proteasesKristina M Orrling, Melissa R Marzahn, Hugo Gutiérrez-de-Terán, et al.
The FEBS Journal|September 29, 2011
Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus proteaseMi Li, Alla Gustchina, Krisztina Matúz, et al.
Journal of Biochemistry|May 2, 2002
A CLN2-related and thermostable serine-carboxyl proteinase, kumamolysin: cloning, expression, and identification of catalytic serine residueHiroshi Oyama, Takatoshi Hamada, Shin Ogasawara, et al.
Biochemical and Biophysical Research Communications|January 22, 2004
Two inhibitor molecules bound in the active site of Pseudomonas sedolisin: a model for the bi-product complex following cleavage of a peptide substrateAlexander Wlodawer, Mi Li, Alla Gustchina, et al.
Pageof 9